Skip to content

A study of whole body cooling and brain injury markers in babies with birth asphyxia

â??Therapeutic Hypothermia and neuronal biomarkers in term neonates with Hypoxic Ischemic Encephalopathy â?? a Randomised Controlled Trialâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011085
Enrollment
150
Registered
2018-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Babies with perinatal asphyxia (hypoxic ischemic encephalopathy stage 2 and 3)

Interventions

Intervention1: Whole body cooling: After obtaining written informed consent from the parents of the babies fulfilling the inclusion criteria, they will be randomized into hypothermia group or control

Sponsors

Department of Biotechnology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gestational age greater than or equal to 37 weeks 2. ABG(umbilical cord or 1st postnatal hour) pH less than or equal to 7 or BE greater than or equal to -12 3. Evidence of encephalopathy (Sarnatâ??s staging 2 or 3) 4. Any two of the following i. APGAR less than or equal to 6 at 5 min ii. Evidence of fetal distress iii. Assisted ventilation for at least 10 min after birth iv. Evidence of any organ dysfunction v. History of acute perinatal event- intrapartum fetal distress, cord prolapse placental abruption, uterine rupture, maternal trauma, cardiac arrest

Exclusion criteria

Exclusion criteria: 1. . Infants more than 6 hours of age at the time of randomization 2. Major congenital abnormalities 3. If the baby does not establish spontaneous respiration by 20 minutes 4. Out born babies

Design outcomes

Primary

MeasureTime frame
Mortality and developmental delay at 18 months of age in HIE infants of hypothermia and control group using DASII (Developmental Assessment Scale for Indian Infants) and correlating them with the blood levels of neuronal biomarkers.Timepoint: 18 months

Secondary

MeasureTime frame
difference in the biomarker levels between the two groupsTimepoint: during hospital stay;complications and adverse eventsTimepoint: during hospital stay;cut off values for biomarkers in relation to primary outcomeTimepoint: 18 months;Developmental delayTimepoint: 18 months;MortalityTimepoint: during hospital stay

Countries

India

Contacts

Public ContactDr B Vishnu Bhat

Jawaharlal Institute of Postgraduate Medical Education and Research

drvishnubhat@yahoo.com09842351282

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026